BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36264078)

  • 1. The Validity of Health-Related Quality of Life Instruments in Patients With Late-Stage Parkinson's Disease.
    Ramadhan M; Schrag A;
    J Geriatr Psychiatry Neurol; 2023 May; 36(3):225-232. PubMed ID: 36264078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Should We Capture Health State Utility in Dementia? Comparisons of DEMQOL-Proxy-U and of Self- and Proxy-Completed EQ-5D-5L.
    Martin A; Meads D; Griffiths AW; Surr CA
    Value Health; 2019 Dec; 22(12):1417-1426. PubMed ID: 31806199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability and validity of a self-administration version of DEMQOL-Proxy.
    Hendriks AAJ; Smith SC; Chrysanthaki T; Black N
    Int J Geriatr Psychiatry; 2017 Jul; 32(7):734-741. PubMed ID: 27272129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How does the EQ-5D perform when measuring quality of life in dementia against two other dementia-specific outcome measures?
    Aguirre E; Kang S; Hoare Z; Edwards RT; Orrell M
    Qual Life Res; 2016 Jan; 25(1):45-9. PubMed ID: 26163146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An empirical comparison of the measurement properties of the EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U for older people in residential care.
    Easton T; Milte R; Crotty M; Ratcliffe J
    Qual Life Res; 2018 May; 27(5):1283-1294. PubMed ID: 29305782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the construct validity and responsiveness of preference-based quality of life measures in people with Parkinson's: a systematic review.
    Xin Y; McIntosh E
    Qual Life Res; 2017 Jan; 26(1):1-23. PubMed ID: 27778141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease severity accounts for minimal variance of quality of life in people with dementia and their carers: analyses of cross-sectional data from the MODEM study.
    Farina N; King D; Burgon C; Berwald S; Bustard E; Feeney Y; Habibi R; Comas-Herrera A; Knapp M; Banerjee S;
    BMC Geriatr; 2020 Jul; 20(1):232. PubMed ID: 32631252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Empirical Comparison of the EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U in a Post-Hospitalisation Population of Frail Older People Living in Residential Aged Care.
    Ratcliffe J; Flint T; Easton T; Killington M; Cameron I; Davies O; Whitehead C; Kurrle S; Miller M; Liu E; Crotty M
    Appl Health Econ Health Policy; 2017 Jun; 15(3):399-412. PubMed ID: 27882528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability and Validity of the EQ-5D in Patients Living With Dementia.
    Michalowsky B; Xie F; Kohlmann T; Gräske J; Wübbeler M; Thyrian JR; Hoffmann W
    Value Health; 2020 Jun; 23(6):760-767. PubMed ID: 32540234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of the PDQ-39 to EQ-5D scores in patients with Parkinson's disease.
    Young MK; Ng SK; Mellick G; Scuffham PA
    Qual Life Res; 2013 Jun; 22(5):1065-72. PubMed ID: 22782690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is EQ-5D a valid quality of life instrument in patients with Parkinson's disease? A study in Singapore.
    Luo N; Low S; Lau PN; Au WL; Tan LC
    Ann Acad Med Singap; 2009 Jun; 38(6):521-8. PubMed ID: 19565103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the psychometric properties of EQ-5D-3L and EQ-5D-5L proxy ratings by informal caregivers and a health professional for people with dementia.
    Michalowsky B; Hoffmann W; Mohr W; Rädke A; Xie F
    Health Qual Life Outcomes; 2022 Oct; 20(1):140. PubMed ID: 36199138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the psychometric performance of EQ-5D-5L in dementia: a systematic review.
    Keetharuth AD; Hussain H; Rowen D; Wailoo A
    Health Qual Life Outcomes; 2022 Sep; 20(1):139. PubMed ID: 36171595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life in a German cohort of Parkinson's patients assessed with three different measures.
    Balzer-Geldsetzer M; Klotsche J; ; Dodel R; Riedel O
    J Neurol; 2018 Nov; 265(11):2713-2722. PubMed ID: 30209651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convergent validation of EQ-5D-5L in patients with Parkinson's disease.
    Alvarado-Bolaños A; Cervantes-Arriaga A; Rodríguez-Violante M; Llorens-Arenas R; Calderón-Fajardo H; Millán-Cepeda R; Leal-Ortega R; Estrada-Bellmann I; Zuñiga-Ramírez C
    J Neurol Sci; 2015 Nov; 358(1-2):53-7. PubMed ID: 26276513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation and comparison of 15-D and EQ-5D-5L instruments in a Spanish Parkinson's disease population sample.
    García-Gordillo M; del Pozo-Cruz B; Adsuar JC; Sánchez-Martínez FI; Abellán-Perpiñán JM
    Qual Life Res; 2014 May; 23(4):1315-26. PubMed ID: 24258254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility-based Quality of Life measures in Alzheimer's disease.
    Naglie G; Tomlinson G; Tansey C; Irvine J; Ritvo P; Black SE; Freedman M; Silberfeld M; Krahn M
    Qual Life Res; 2006 May; 15(4):631-43. PubMed ID: 16688496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden and health-related quality of life among caregivers of Brazilian Parkinson's disease patients.
    Carod-Artal FJ; Mesquita HM; Ziomkowski S; Martinez-Martin P
    Parkinsonism Relat Disord; 2013 Nov; 19(11):943-8. PubMed ID: 23831481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responsiveness of the EQ-5D and 8-item Parkinson's Disease Questionnaire (PDQ-8) in a 4-year follow-up study.
    Luo N; Ng WY; Lau PN; Au WL; Tan LC
    Qual Life Res; 2010 May; 19(4):565-9. PubMed ID: 20204708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation study of the prototype of a disease-specific index measure for health-related quality of life in dementia.
    Schölzel-Dorenbos CJ; Arons AM; Wammes JJ; Rikkert MG; Krabbe PF
    Health Qual Life Outcomes; 2012 Sep; 10():118. PubMed ID: 23009579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.